| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $8K | -91.4% |
| Cost of Revenue | $2K | -95.4% |
| R&D Expense | $1.5M | +66.4% |
| SG&A Expense | $3.6M | +25.6% |
| Operating Income | -$5.1M | -35.2% |
| Interest Expense | $777K | +300.3% |
| Pre-tax Income | -$5.2M | -38.2% |
| Income Tax | $0 | — |
| Net Income | -$5.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $118K | -36.9% |
| Total Assets | $386K | -0.8% |
| Current Liabilities | $8.2M | +27.6% |
| Total Liabilities | $12.7M | +23.2% |
| Stockholders' Equity | -$12.1M | -23.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.1M | +40.8% |
| Financing Cash Flow | $1.1M | -39.5% |
| -38.2% |